Blockade of Estrogen Receptor Signaling Inhibits Growth and Migration of Medulloblastoma
Open Access
- 13 November 2008
- journal article
- other
- Published by The Endocrine Society in Endocrinology
- Vol. 150 (3) , 1112-1121
Abstract
Medulloblastoma (MD) is the most common malignant brain tumor in children. These invasive neuroectodermal tumors arise from cerebellar granule cell-like precursors. In the developing cerebellum, estrogen influences growth and viability of granule cell precursors that transiently express elevated levels estrogen receptor-β (ERβ) during differentiation. Immunoanalysis revealed that ERβ was expressed in the maturing human cerebellum, in all 22 primary MD tumors analyzed, and in two MD-derived cell lines (D283Med and Daoy). Very low levels of ERα-like proteins were detected in each cell line and 41% of tumor samples. Physiological concentrations of the 17β-estradiol- or the ERβ-selective agonist 2,3-bis(4-hydroxyphenyl)-propionitrile diarylpropionitrile dose-dependently increased MD growth and cellular migration. In contrast, the ERα-selective agonist (4-propyl-[1H]pyrazole-1,3,5-triyl) trisphenol did not influence MD growth. Similar to previous studies in normal cerebellar granule cell precursors, these studies demonstrate that the physiological actions of estrogens in MD are mediated by ERβ. Preclinical studies assessing the therapeutic efficacy of antiestrogen chemotherapeutics for treating human MD were performed. It was found that pharmacological inhibition of ER-mediated signaling with the ER antagonist drug Faslodex (ICI182,780) blocked all estrogen-mediated effects in both cell culture and xenograft models of human MD. These studies have revealed that functional ERβ expression is a fundamental aspect of MD biology and has defined antiestrogen therapy as a potentially efficacious clinical approach to improve the long-term outcomes for MD patients. Estrogens, via ERβ, stimulate growth of medulloblastoma. ICI182,780 and the antiestrogen drug Faslodex block estrogen-stimulated tumor growth in vitro and in xenograft models of medulloblastoma.Keywords
This publication has 49 references indexed in Scilit:
- Chapel Hill bisphenol A expert panel consensus statement: Integration of mechanisms, effects in animals and potential to impact human health at current levels of exposureReproductive Toxicology, 2007
- Development and evolution of therapies targeted to the estrogen receptor for the treatment and prevention of breast cancerSteroids, 2007
- Phase 2 trial of radiation plus high-dose tamoxifen for glioblastoma multiforme: RTOG protocol BR-00211Neuro-Oncology, 2006
- Estrogen receptor beta is expressed in human embryonic brain cells and is regulated by 17β‐estradiolEuropean Journal of Neuroscience, 2004
- Estrogen receptor expression in a human primitive neuroectodermal tumor cell line from the cerebral cortex: estrogen stimulates rapid ERK1/2 activation and receptor-dependent cell migrationBiochemical and Biophysical Research Communications, 2004
- Estrogen receptor beta (ER?) is expressed in brain astrocytic tumors and declines with dedifferentiation of the neoplasmJournal of Cancer Research and Clinical Oncology, 2004
- Histopathologic grading of medulloblastomasCancer, 2002
- Hormones and Hormone Antagonists: Mechanisms of Action in Carcinogenesis of Endometrial and Breast CancerHormone and Metabolic Research, 2001
- Regulated expression of estrogen receptor α and β mRNA in granule cells during development of the rat cerebellumDevelopmental Brain Research, 1999
- Cloning and Characterization of Human Estrogen Receptor β IsoformsBiochemical and Biophysical Research Communications, 1998